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ABSTRACT 
Reactive oxygen species (ROS) are reduced forms of oxygen created as byproducts of 
cellular metabolic processes.  ROS cause oxidative damage to many organic molecules within 
the cell, especially to DNA.  OXR2 provides cells with protection against this damage, but its 
biochemical and functional properties have not yet been studied in depth.  The purpose of this 
project was to create and purify a His-tagged version of human OXR2 and to induce a FLAG-
tagged OXR2 in E.  coli.  These tagged proteins will be used in studies of this protein and its 
mechanism.  
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BACKGROUND
REACTIVE OXYGEN SPECIES AND OXIDATIVE DA
 Reactive oxygen species (ROS)
are created as byproducts of the metabolic reactions that naturally occur in the cell 
Reactive oxygen species include superoxide (O
radicals (OH.; See Figure 1).   
Figure 1: The Steps of Reduction of Molecular Oxygen to Water
include O2-., H2O2, and OH.  (Imlay, 2003)
 
While molecular oxygen is a poor oxidant, reactive oxygen species are far better electron 
acceptors and are therefore better oxidants 
reactive of these species.  It is so reactiv
the cell (Imlay, 2003).  The hydroxyl radical reacts with the first molecule with which it 
interacts.  Hydrogen peroxide is a slightly 
that reduces its reactivity (Imlay, 2003)
molecule’s negative charge inhibits it from accepting electrons from other negatively charged 
molecules (Imlay, 2003).  Oxidation by reactive oxygen species leads to a wide range of damage 
to biomolecules, such as nucleic acids, proteins, and lipids 
  
 
MAGE 
 are partially reduced species of molecular oxygen
(Imlay, 2003)
2
-.), hydrogen peroxide (H2O2), and hydroxide 
 
.  Note that ROS molecules 
. 
(Imlay, 2003).  The hydroxyl radical is the most 
e that it is only inhibited by the rate of diffusion within 
less reactive oxidant.  It contains a stable O-O bond 
.  Superoxide is also slightly less reactive.  The 
(Croteau & Bohr, 1997). 
.  They 
.  
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Formation of Superoxide and Hydrogen Peroxide 
  Reactive oxygen species are created during metabolic processes in the cell.  This was 
determined through studies of superoxide dismutase (SOD) mutants.  SOD helps to neutralize 
superoxide in the cell.  SOD mutants have abnormally high levels of oxidative damage that can 
be attributed to high levels of ROS in the cell (Carlioz & Touati, 1986).  This accumulation in 
SOD mutants indicates that reactive oxygen species are created normally in the cell, but that the 
buildup is prevented by antioxidants like SOD in wild type organisms (Carlioz & Touati, 1986). 
 Three forms of SOD are found in humans.  SOD1, SOD2, and SOD3 are found in the 
cytoplasm, mitochondria, and extracellular matrix, respectively (Slupphaug, et al., 2003).  
Studies involving mutants in mitochondrial SOD have shown that superoxide and hydrogen 
peroxide naturally accumulate in the mitochondria of a cell (Lebovitz, et al., 1996).  This 
suggests that normal mitochondrial processes lead to reactive oxygen accumulation.  More 
specifically, the ubiquinone site of Complex III, and the FMN site of complex I in the electron 
transport chain have been found to be two major sites of superoxide and hydrogen peroxide 
formation in the cell (Turrens & Boveris, 1980; Liu, et al., 2002; Dröse & Brandt, 2008).   
 Complex III (also known as the cytochrome bc1 complex) of the electron transport chain 
forms large amounts of reactive oxygen species under certain conditions.  The normal 
mechanism of Complex III is shown in Figure 2A.  Electrons are transported from ubiquinol to 
the bL heme group of complex III, then to the bH heme group, and finally to ubiquinone (Dröse & 
Brandt, 2008). 
Antimycin A is an N-site inhibitor which interrupts the flow of electrons in Complex III 
(Dröse & Brandt, 2008; See Figure 2B).  This interruption causes reverse electron flow which 
reduces ubiquinone to a ubiquinone radical (Dröse & Brandt, 2008).  The radical reduces 
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molecular oxygen, creating superoxide (Dröse & Brandt, 2008).  According to Dröse & Boveris 
(2008), a reduced ubiquinone pool and the presence of antimycin A cause complex I to perform 
reverse electron transfer.  These conditions, however, may not be physiologically relevant, as no 
molecule that acts similarly to antimycin A has been found in nature.  In natural systems, this 
may not be a major mechanism of superoxide production (Liu, et al., 2002).   
 
Figure 2: The Electron Transport Chain's Complex III.  (A) The normal mechanism of 
complex III; (B) The mechanism by which complex III produces superoxide in the presence of 
antimycin A (Q – ubiquinone, QH2 – ubiquinol, Q-. – partially reduces ubiquinone radical)   (Dröse 
& Brandt, 2008)  
 
 A second source of ROS production in the electron transport chain may be more 
physiologically relevant.  Complex I (also called NADH dehydrogenase) produces lower levels 
of superoxide and hydrogen peroxide than antimycin A inhibited Complex III, but does produce 
ROS at physiological conditions.  The normal mechanism of Complex I is shown in Figure 3A.  
Complex I also produces superoxide and hydrogen peroxide via reverse electron transfer (Figure 
3B).  In complex I, reactive oxygen species are created at the NADH binding site by a reduced 
flavin molecule (Esterházy, et al., 2008).  Electrons are passed from the reduced flavin molecule 
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to molecular oxygen instead of to the Q-site of the enzyme (Esterházy, et al., 2008).  This 
mechanism is supported by the observation that when a Q-site inhibitor of complex I is present, 
the production of reactive oxygen species increases (Esterházy, et al., 2008).  Many other 
flavoproteins perform this same mechanism during autoxidation of their flavin cofactor (Imlay, 
2003).  Succinate dehydrogenase and fumarate dehydrogenase also follow this mechanism in 
producing reactive oxygen species (Imlay, 2003). 
 
Figure 3:  The Electron Transport Chain's Complex I.  (A) The normal mechanism of 
Complex I; (B) The mechanism by which complex I produces superoxide and hydrogen peroxide 
via reverse electron transfer (Esterházy, et al., 2008). 
 
Hydroxyl Radical Formation 
 The hydroxyl radical (HO.) is the most reactive of the reactive oxygen species.  It is so 
reactive that it is only limited by its diffusion and reacts with the first molecule with which it 
comes into contact.  One source of hydroxyl radical formation is Fenton chemistry.  Ferrous iron 
ions react with hydrogen peroxide to form ferric iron, a hydroxyl ion, and a hydroxyl radical.  
The equation for this reaction is shown in Figure 4. 
  
9 
 
 
 
 
This reaction occurs with free iron, which is not associated with proteins or other 
molecules.  The free iron must be reduced from ferric iron (Fe3+) to ferrous iron (Fe2+) to act in 
this reaction (Imlay, 2003).  This reduction can be performed by molecules like FADH2, 
cysteine, or superoxide (Imlay, 2003). 
 
Cell Damage Caused by Superoxide 
 Superoxide is a negatively charged molecule, so it is inhibited from oxidizing other 
negatively charged molecules, such as DNA.  Because of this, superoxide is not an efficient 
oxidant.  Most of the cellular damage caused by superoxide can be attributed to the formation of 
hydroxyl radicals through the Haber-Weiss reactions (See Figure 5). 
 
 
 
Many proteins containing iron-sulfur clusters are inactivated by superoxide itself (Imlay, 
2003).  Dihydroxy-acid dehydratase, transketolase fumarase A, fumarase B, and mammalian 
aconitase are all enzymes that are inactivated by superoxide due to the destruction of iron-sulfur 
clusters (Flint, et al., 1993; Benov, 2001).  The mechanism of iron-sulfur cluster damage by 
superoxide is shown in Figure 6.   
H2O2 + Fe2+   OH- + FeO2+ + H+  Fe3+ + 
OH- + HO. 
Figure 4: The Fenton Reaction for the Formation of the Hydroxyl Radical (Benov, 2001). 
Fe3+ + O2-  Fe2+ + O2 
H2O2 + Fe2+  Fe3+ + OH- + HO. 
Figure 5: The Haber-Weiss Reactions that Form Hydroxyl Radical from Superoxide and 
Hydrogen Peroxide (Benov, 2001). 
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Figure 6: Mechanism of Inactivation of Iron-Sulfur Clusters by Superoxide.  (Flint, et al., 
1993) 
 
The overall reaction of the mechanism shown in Figure 6 is:  
[4Fe-4S2+] + O2- + 2H+   [3Fe-4S1+] + H2O2 + Fe2+. 
First, superoxide binds to ferrous iron (Fe2+) in the iron-sulfur clusters in the active site of an 
enzyme (Flint, et al., 1993).  Superoxide then recruits two hydrogen ions from the active site of 
the enzyme to form hydrogen peroxide (Flint, et al., 1993).  Hydrogen peroxide oxidizes the 
ferrous iron in the cluster to ferric iron (Fe3+), forming a hydroxyl radical (Flint, et al., 1993).  
Because sulfide has a lower affinity to Fe3+ than to Fe2+, the iron ion is released, and the cluster 
is inactivated (Flint, et al., 1993). 
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Cell Damage Caused by Hydrogen Peroxide 
 Hydrogen peroxide is another oxidant of biomolecules in the cell.  Like superoxide, much 
of the damage from hydrogen peroxide in the cell can be attributed to the formation of hydroxyl 
radicals via the Haber-Weiss reactions (See Figure 5).  Hydrogen peroxide can, however, oxidize 
methionine residues, cysteine residues, ferric iron, and iron sulfur clusters (Imlay, 2003). 
 A major target for hydrogen peroxide-induced damage is sulfur atoms.  Hydrogen 
peroxide can oxidize sulfur atoms in cysteine residues of amino acids (Imlay, 2003).  This can be 
drastic to proteins with catalytic cysteine residues.  Denu & Tanner (1998) studied tyrosine 
phosphatases’ inactivation in the presence of hydrogen peroxide.  The catalytic cysteine residues 
of these enzymes are inactivated when oxidized by hydrogen peroxide.  This same inactivation 
has been seen in Recombinant Human α1-antitrypsin and glutathione transferase (Shen, et al., 
1993; Griffiths, et al., 2002).  The oxidation of these residues to sulfenic acid residues can cause 
disulfide bridges within a protein.  Sulfenic acid residues can also be reduced further to sulfinic 
acid residues.  These alterations can ruin catalytic cysteine residues, or severely alter the 
structure of proteins.   
 
Cell Damage by Hydroxyl Radical 
 A wide range of damage can occur in the cell in the presence of the hydroxyl radical.  
Two targets of the hydroxyl radical that can lead to the most drastic damage in the cell are 
membrane lipids and nucleic acids.  Polyunsaturated fatty acids that are found in membrane 
phospholipids are a huge target of hydroxyl radical oxidation (Marnett, 2000).  There are 
methylene groups between the cis double bonds of these unsaturated fatty acids, which react with 
the hydroxyl radical and form carbon centered radicals (Marnett, 1999).  The effects of this 
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oxidation can be drastic.  Because there are so many lipid molecules packed tightly together in a 
membrane, a chain reaction of lipid peroxidation can lead to the oxidation of a large number of 
molecules from a single hydroxyl radical.  This can severely damage the membrane. 
The products of lipid peroxidation are very diverse.  There are several pathways of 
reconciliation of the carbon centered radicals that are formed during the reaction of methylene 
groups and hydroxyl radicals.  In addition to membrane damage, lipid peroxidation creates 
products that can damage the cell in other ways.  One such molecule is 4-hydroxynonenal 
(HNE).  HNE causes a wide range of damage within the cell.  It modifies cysteine, histidine, and 
lysine residues of amino acids (Catalá, 2009).  These modifications can inactivate important 
proteins, leading to alterations in DNA and protein synthesis and gene regulation (Catalá, 2009).  
These effects can be extremely damaging to the cell. 
 Malondialdehyde (MDA) is another product of lipid peroxidation that can cause severe 
cell damage.  MDA reacts very well with DNA, more specifically dG, dA, and dC residues 
(Marnett, 2000).  Exposure of DNA to MDA results most commonly in G to T transversions 
(Marnett, 1999).  It can also result in C to T and A to G transitions, and more rarely frameshift 
addition of nucleotides (Marnett, 1999). 
 As discussed above, hydroxyl radicals are created through Fenton chemistry with iron 
ions.  Iron ions bind very well with DNA molecules, and the close proximity to DNA during 
formation makes DNA a huge target of hydroxyl radical oxidation (Imlay, 2003).  A common 
lesion of DNA by reactive oxygen species is 8-oxoguanine (See Figure 7). 
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Figure 7:  Diagram of 8-oxoguanine, a Common Lesion in DNA Induced by ROS.  (A) 
Guanine; (B) 8-oxoguanine induced by ROS (Marnett, 2000) 
 
 Oxidative damage to DNA is possibly the most severe form of damage that is induced by 
ROS.  When nucleotide bases are oxidized, transversions and frameshift mutations can 
accumulate in the cell.  This can lead to nonfunctional proteins, or changes in gene regulation 
and the cell cycle.  Oxidative damage to DNA is linked to aging, cancer, and many other forms 
of human pathogenesis. 
 
OXIDATIVE DAMAGE PREVENTION AND REPAIR 
 Because reactive oxygen species incur so much damage to cells, they have developed 
complex mechanisms of oxidative damage prevention and repair.  The mechanisms that cells use 
to prevent this damage include enzymes that convert reactive oxygen species to harmless 
molecules of water and oxygen.  Because damage occurs even with these preventative enzymes, 
complex mechanisms of DNA, lipid, and protein repair exist.  These mechanisms will be 
described in more detail in this section. 
 
Oxidative Damage Prevention 
 Because vital processes, such as the mitochondrial electron transport chain, are constantly 
creating reactive oxygen species in the cell, they have developed mechanisms to keep the cellular 
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levels to a minimum.  Antioxidant enzymes break down these dangerous oxidants into harmless 
molecules of water and oxygen.  To eliminate superoxide from the cell, human cells have three 
forms of the enzyme superoxide dismutase.  This enzyme breaks superoxide into oxygen and less 
reactive hydrogen peroxide by the following reaction:  
2O2- + 2H+   O2 + H2O2 (Slupphaug, et al., 2003). 
The second protection enzyme in most cells is catalase.  This enzyme converts hydrogen 
peroxide into water and oxygen in the following reactions:  
2H2O2  2H2O + O2 (Slupphaug, et al., 2003). 
Selenium-dependant GSH peroxidase performs a similar reaction of converting hydrogen 
peroxide to harmless water and oxygen (Fang, et al., 2002). 
 Vitamins can also act as antioxidants.  Vitamin E can reduce peroxyl radicals in 
polyunsaturated fatty acids in phospholipids (Fang, et al., 2002).  When these radicals are located 
in a membrane, this will stop the chain reaction of lipid peroxidation and prevent further damage.  
Vitamin C has been shown to protect DNA from oxidative damage, and B vitamins are thought 
to protect from amino acid oxidation (Fang, et al., 2002).  These mechanisms have not been well 
established (Fang, et al., 2002).   
 
Oxidative DNA Damage Repair 
 Even with the preventative measures described above, cells are still damaged by reactive 
oxygen species.  One of the most severe forms of damage that the cell can sustain is DNA 
damage.  DNA damage can lead to mutations within important genes, leading to mutated gene 
products.  It can also lead to the misregulation of genes.  The consequences of oxidative DNA 
damage are extremely wide, and range from harmless to fatal.   
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 One mechanism of repair of an oxidized DNA is base excision repair (BER).  In BER an 
oxidized nucleotide base is recognized, removed, and replaced with a normal nucleotide.  First, a 
DNA glycosylase recognizes a damaged base and removes it, forming an abasic site (AP site) 
(Slupphaug, et al., 2003).  There are two types of DNA glycosylase.  Monofunctional 
glycosylases stop at this stage, leaving the DNA backbone intact (Lu, et al., 2001).  All of the 
known glycosylases that recognize oxidized bases are bifunctional (Lu, et al., 2001).  These 
enzymes also create a nick in the DNA backbone at the 3’ side of the AP site (Lu, et al., 2001).  
There are many DNA glycosylases, and all recognize a specific type of DNA damage.   
 After a damaged base has been removed, and the backbone has been nicked, an AP 
endonuclease will cleave the DNA backbone on the 5’ side of the AP site (Slupphaug, et al., 
2003).  This releases the deoxyribose molecule that was bound to the oxidized base.  This step 
differs if a NEIL family glycosylase recognizes and excises the mutated base.  These 
glycosylases leave a 3’ phosphate terminus when the base is removed (Wiederhold, et al., 2004).  
This is a poor substrate for AP endonucleases, so a polynucleotide kinsase removes the 
phosphate, creating the same type of product as the AP endonuclease reaction (Wiederhold, et 
al., 2004).   DNA polymerase can then replace the missing nucleotide, and ligase seals the nicks 
in the backbone (Slupphaug, et al., 2003).  Figure 8 shows a diagram of this process.   
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Figure 8: Diagram of the Base Excision Repair
use of DNA glycosylase, AP endonuclease, DNA polymerase, and DNA ligase
al., 2003) 
 
 Another mechanism for repairing altered DNA is nucleotide excision repair (NER)
Unlike BER, NER does not involve the recognitio
nucleotide (de Laat, et al., 1999).  The most common mutations that are corrected by NER are 
caused by ultraviolet radiation or are severe alterations to the DNA backbone (de Laat, et al., 
1999).  There are two types of NER: global genome NER and transcription coupled NER
Global genome NER occurs anywhere in the genome
transcription is blocked by DNA damage and recognized by RNA polymerase (de Laat, et al., 
1999).  In both types of NER, an area of about twenty to thirty nucleotides around the DNA 
damage is unwound, and the damaged strand is removed
removed, it can be replaced by DNA polymerase 
 A third mechanism of DNA repair is mismatch repair (MMR)
DNA damage during DNA replication (Russo, et al., 2007)
been incorrectly matched.  These mismatches are someti
DNA.  Mispaired nucleotide bases are recognized by two heterodimers called MutS
(Russo, et al., 2007).  An endonuclease can then excise the mismatched base
 (BER) Mechanism.  This system involves the 
.  (Slupphaug, et 
n of particular type of alteration to the 
.  Transcription coupled repair occurs when 
 (Wood, 1997).  Once the damage is 
(Wood, 1997). 
.  This mechanism corrects 
.  MMR can recognize bases that have 
mes the result of oxidative damage to 
α and MutL
.  DNA polymerase 
 
.  
.  
α 
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and ligase can then insert the new base and seal the DNA backbone.  This type of DNA repair is 
generally performed on extreme legions that distort the DNA backbone.  A large segment of 
DNA is excised and resynthesized. 
 
OXIDATIVE RESISTANCE GENES 
 In addition to the prevention and repair mechanisms for oxidative damage described 
above, eukaryotic cells contain a group of proteins called oxidative resistance proteins.  The 
mechanisms of these proteins are not well known, but studies have shown that they can protect 
cells from the oxidative damage of reactive oxygen species. 
 
OXR1 
 OXR1 is a gene encoding an oxidative resistance protein.  It was discovered in a screen 
for human genes that conferred oxidative resistance to a repair-defective spontaneous mutator 
strain of E.  coli (Volkert, et al., 2000).  Several genes were found that conferred oxidative 
damage resistance, including one that was named OXR1.  Homologues of this gene are found in 
many eukaryotes, including yeast (Volkert, et al., 2000).  Yeasts deficient in OXR1 are very 
vulnerable to damage by hydrogen peroxide, and the gene is inducible by heat and oxidative 
stress in yeast and humans (Volkert, et al., 2000; Elliott & Volkert, 2004). 
 There are a number of splice variants of OXR1.  The gene has a total of sixteen exons 
that can produce a 99.7 kDa protein (Durand, et al., 2007).  The OXR1 protein is localized in the 
mitochondria in human and yeast (Elliott & Volkert, 2004).  This is probably due to the large 
amount of reactive oxygen species that are created by metabolic reactions in the mitochondria.   
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OXR2 
 The sequence of the OXR1 gene was used to probe the rest of the human genome for 
OXR1 paralogs.  The searches yielded three major results, the most important of which was a 
gene called NCOA7 (Nuclear Receptor Coactivator 7) (Durand, et al., 2007).  This gene is also 
referred to as OXR2 or ERAP140 (Estrogen Receptor-Associated Protein 140).  Most exons of 
OXR2 were found to be very similar to OXR1 (Durand, et al., 2007). 
 Human OXR2 has been found to protect E.  coli from oxidative damage.  Cells 
transformed with OXR2 were protected from 99.9% of GC TA transversions that were induced 
by hydrogen peroxide when compared to wild type controls (Durand, et al., 2007).  Because the 
carboxyl-terminal end of the protein is so conserved, and the carboxyl-terminal exons of OXR1 
were found to be sufficient to confer oxidative resistance in E. coli, studies of transformations 
with amino-terminal deletions of the OXR2 gene were performed (Durand, et al., 2007).  It was 
found that only bases 657-942, the carboxyl-terminal end of the protein, is sufficient to protect E.  
coli from 73% of oxidative damage (Durand, et al., 2007).  This difference in efficiency in 
conferring oxidative resistance between the full length and truncated protein is thought to be 
caused by the greater stability of the full-length gene product in bacteria (Durand, et al., 2007). 
 OXR2 and OXR1 are not identical.  OXR2 is localized in the nucleus and cytoplasm, but 
not the mitochondria specifically (Durand, et al., 2007).  This protein is not inducible by 
oxidative damage, unlike OXR1, and is known to associate with an estrogen receptor (Durand, et 
al., 2007). 
Almost nothing is known about the mechanism of oxidative damage protection of OXR2.  
Because the biochemical and functional properties of the protein are unknown, it is difficult to 
determine an efficient way to purify this protein.  Another method of purification must be used in 
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order to purify the protein to be used in studies of its function and properties.  One method is 
affinity tagging. 
 
PROTEIN AFFINITY TAGGING 
 An affinity tag for proteins is an “exogenous amino acid (aa) sequence with a high 
affinity for a specific biological or chemical ligand” (Arnau, et al., 2006).  Currently, a vast 
number of tagged-proteins are being studied and produced.  In order to work with these proteins, 
they must be purified.  Before affinity tags, the biochemical properties of each protein had to be 
studied, and a unique method of purification had to be determined.  With affinity tags, a wide 
range of proteins can be purified with a single method.  This technique is especially helpful in 
the early stages of research on a protein, when biochemical and functional studies have not yet 
been performed (Arnau, et al., 2006).  Affinity tagging can increase the yield of purification, and 
can often stabilize a protein by protecting it from proteolysis (Arnau, et al., 2006). 
 However, there are some disadvantages to using affinity tags.  The added amino acids of 
some tags can change the conformation of certain proteins which can affect function (Arnau, et 
al., 2006).  They can also inhibit activity if they interfere with an enzyme’s active site, or 
increase a protein’s toxicity (Arnau, et al., 2006). 
 
His-Tagging 
 One of the most popular affinity tags is the His-tag.  About 60% of protein structural 
studies have been performed using this type of tag which consists of a series of about six 
histidine residues (Arnau, et al., 2006).  The residues can be placed on either the amino-terminus 
or the carboxyl-terminus of the protein (Arnau, et al., 2006). 
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Immobilized metal ion affinity chromatography (IMAC) is performed to purify His-
tagged proteins (Waugh, 2005).  This process involves running a cell extract through a nickel-
sepharose column.  The histidine residues of the tag can bind to the immobilized nickel (Arnau, 
et al., 2006).  His-tags are very common due to the low cost of the purifying resin and the mild 
conditions needed for protein elution (Waugh, 2005).  Unfortunately, they should not be used on 
proteins for which metal binding assays are required, due to the tag’s affinity for metal.  Another 
disadvantage of His-tags is the lower specificity in purification compared to some other affinity 
tags. 
 
FLAG-Tagging 
 A second common affinity tag is the FLAG-tag.  This is a hydrophilic series of eight 
amino acids: DDYKDDDK (Arnau, et al., 2006).  Unlike the His-tag, it uses calcium-dependant 
antibody purification (Arnau, et al., 2006).  This purification has a higher specificity than IMAC, 
although the resin is far more expensive (Waugh, 2005).  The elution conditions of this tag are 
also harsher, and may cause damage to some proteins (Waugh, 2005).  
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PROJECT PURPOSE 
As discussed in the Background, reactive oxygen species (ROS) cause oxidative damage 
to many organic molecules within the cell, especially to DNA.  Human OXR2 is a protein that 
provides cells with protection against this damage; however its properties have not yet been 
studied in depth.  Thus the main purpose of this project was to create and purify tagged versions 
of OXR2 to be used in future studies of its mechanism. 
The initial purpose of this project was to produce, induce, and purify a His-tagged version 
of OXR2 (OXR2-his6), but in the process of completing this goal, several interesting 
observations were made about the selection against cells containing this his-tagged protein and 
the degradation of this protein in E.  coli.  So the initial goal was modified to include an addition 
to this line of research, production of a FLAG-tagged version of OXR2 (OXR2-FLAG).  Both of 
the tagged proteins created in this project can be used in future research involving OXR2. 
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METHODS 
E.  COLI  STRAINS, PLASMIDS, AND PRIMERS 
Strain Number Cell Type and Plasmid Inserted Induced Phenotype 
MV3594 Q cells + pTrc vector No OXR2 
MV6301 Q cells + pMV1200 WT-OXR2 
MV6658 Q cells + pMV1202 OXR2-his6 (for induction 
experiments) 
MV6659 Q cells + pMV1203 OXR2-his6 (mutated His) 
MV6660 BL21 cells + OXR2-FLAG OXR2-FLAG 
Table 1: Table of E.  coli Used in this Project. 
 
Plasmid Name Vector Insert 
pMV1200 pTrc promoter, Ampr Human WT-OXR2 
pMV1202 pTrc vector Human OXR2-his6 
pMV1203 pTrc vector Human OXR2-his6  (mutated His) 
pcDNA3-FLAG-ERAP140 pcDNA3-FLAG Human OXR2-FLAG 
Table 2: Table of Plasmids Used in This Project. 
 
Primer 
Number Primer Name Sequence (5’-3’) Use 
329 OXR2-his up ATGTTCCTGTGCATCAAAG Production of human 
OXR2-his6 PCR 
Product 330 OXR2-his Tag 
GCGCAAGCTTCAGTGATGATGATGATGAT
GATCAAATGCCCACACCTCCAGATCC 
333 OXR2 inside 1 CCTGGAGAATATGCACATCG PCR Product 
Sequencing 334 OXR2 inside 2 ATGCCGATTTCCGGTAGAG 
Table 3: Table of Primers Used in This Project. 
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HIS-TAGGING OXR2 
PCR 
The His-tagged OXR2 gene used in this project was produced from a previously created 
plasmid (pMV1200, a pTrc99a cloning vector) containing the human wild-type OXR2 gene.  
The vector contains a Trc promoter directly upstream of the OXR2 gene, an ampicillin resistance 
gene, the pBR322 origin of replication, and the LacI gene.  pMV1200 was isolated from the E.  
coli strain MV6301 using Qiagen’s QIAprep® Miniprep kit. 
A PCR product was created using primers 329 (ATGTTCCTGTGCATCAAAG) and 330 
(GCGCAAGCTTCAGTGATGATGATGATGATGATCAAATGCCCACACCTCCAGATCC).  
Primer 329 (OXR2-his up) is the sequence of coding strand of OXR2 from base pair 1969 to 
base pair 1987.  Primer 330 (OXR2-his Tag) contains the sequence of the last 25 bases of the 
OXR2 template strand before the stop codon, six histidine codons, a stop codon overlapping a 
HinDIII site, and four extra bases (See Figure 9). 
This PCR product contains the DNA sequence for the carboxyl-terminal end of OXR2 
from base pair 1969 in reading frame with six histidine codons inserted before the translational 
stop codon, and a HinDIII site (See Figure 9).  The PCR product was purified by gel 
electrophoresis and extracted using Qiagen’s QIAquick® PCR purification kit.  The product was 
then analyzed by gel electrophoresis. 
The OXR2 gene contains a PstI site near the carboxyl-terminal end of the coding 
sequence.  This site is located in pMV1200 and in the PCR product.  A HinDIII site is present at 
the end of the PCR product and in pMV1200 just beyond the end of the OXR2 gene (See Figure 
9).  The PCR product and pMV1200 were double digested with PstI and HinDIII in New 
England Biolabs’ reaction buffer 2 and 0.1 mg/ml BSA for one hour at 37°C.  The digests were 
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purified by electrophoresis and extracted using Qiagen’s QIAquick® gel extraction kit for the 
first several tries.  To increase the efficiency of transformation in later trials, this gel extraction 
step was removed and the restriction enzymes were inactivated by heat at 65°C for twenty 
minutes before ligation. 
 
Figure 9: Design of OXR2-His6.  (A) Map of pMV1200 and the primers used to create PCR 
product containing the His-tag.  (B) Map of the expected PCR product.  (C) Map of expected 
ligation product of the PstI and HinDIII double digested pMV1200 and PCR product. 
 
DNA Ligations 
The two digests were ligated together using three different methods of ligation.  First, 
New England Biolabs’ Quick Ligase kit was used.  The digests were ligated at room temperature 
for 10 minutes.  To try to increase the efficiency of the process, T4 ligase was also used at 16°C 
overnight. 
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Transformation of E.  coli with pMV1203 and pMV1202 
The products of the ligation reactions were used to transform competent Q cells.  Two 
strategies of transformation were used: transformation and electroporation. 
 
Transformation of Competent Q Cells 
The E.  coli Q strain cells were made competent in Dr.  Volkert’s lab.  The cells were 
grown overnight in LB medium and diluted 1:20 in LB medium.  They were grown to about 2.5 
x 108 cells/mL at 37°C, then were centrifuged and resuspended in 5 mL of CP20 (0.5 mM Pipes, 
pH 6.8, 0.05 M CaCl2) + 15% glycerol and stored at - 80°C until use. CP20 is  
Competent Q cells (E. coli W3110 lacIq) were incubated on ice for 45 minutes with either 
no DNA, ligation product, or 50 ng of pMV1200.  The cells were heat shocked for 2 minutes at 
37°C, and then incubated at room temperature for 10 minutes.  The cells were incubated in 1 mL 
of Luria-Bertani (LB) Broth (10 g/L Bacto-tryptone, 5 g/L yeast extract, 10 g/L NaCl) for 1 hour, 
and then plated on LB-ampicillin (100 µg/µl) plates.  The plates were grown at 37°C overnight.   
Two transformants were produced by this method.  They were purified and named strains 
MV6658 and MV6659. 
 
Preparing Q Cells for Electroporation 
An overnight culture of Q cells was diluted 1:40 and grown to a cell density of 107 
cells/mL at 30°C.  IPTG was added to a concentration of 1 mM.  The cells were grown to a cell 
density of 3.5 x 108 cells/mL.  They were then heat shocked at 42°C for 15 minutes.  The cells 
were centrifuged at 6000 rpm for 5 minutes, the supernatant was discarded, and the cells were 
resuspended in 1 mM MOPS, 20% glycerol.  The cells were centrifuged at 10,000 rpm for 1 
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minute, the supernatant was discarded, and the cells resuspended in 1 mL of 1.0 mM MOPS, 
20% glycerol twice.  Finally the cells were centrifuged at 10,000 rpm a last time, the supernatant 
was discarded and were resuspended in 100 µL 1.0 mM MOPS, 20% glycerol. 
 
Electroporation of Q Cells 
The Q cells that were made competent for electroporation were chilled in cuvettes with 
either no DNA, ligation product, or pMV1200.  The air was tapped out of the cuvettes, and they 
were placed in the electroporation machine.  The cells were shocked for 1 second with 2000 
volts, and 300 µL of LB was added to the cuvettes.  The cells were removed from the cuvette, 
suspended in 3 mL of LB, and incubated at 37°C for one hour.  They were then plated on LB-
ampicillin plates and grown overnight at 37°C.   
 
Induction of His-Tagged OXR2 
The induction of OXR2-his6 was performed on strains: MV6658 and MV6659.  Because 
the plasmid from strain MV6658 was found to be mutant by sequencing from Sequegen, only the 
results from the induction and purification of strain MV6659 are discussed in this report.  For 
each induction, there were two controls.  One was uninduced transformant strain MV6659.  The 
second control was an IPTG induced strain MV3594, which is identical to MV6659, but contains 
a vector control plasmid pTrc99A with no OXR2 insert. 
Two overnight cultures of the transformant strain and one overnight culture of strain 
MV3594 were diluted 1:50, then grown at 37°C for 1 hour.  IPTG was added to cultures of 
MV3594 culture and MV6659 to a final concentration of 2 mM, and the cells were grown for 3 
hours at 37°C.  Samples of the cells were taken at the point of IPTG addition, and also at 
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subsequent time points of 1 hour, 2 hours, and 3 hours.  The induction of OXR2 was analyzed by 
Coomassie staining of an SDS-PAGE gel and by Western blot. 
 
Purification of His-Tagged OXR2 
His-tagged OXR2 was purified from a culture of MV6659 cells that were induced with 
IPTG and grown for three hours.  The cells were lysed by freeze-thawing and by treatment with 
lysozyme.  A His-spin protein miniprep kit from Zymo Research was used to purify the His-
tagged protein from the cell extract.  The purification was analyzed by Coomassie staining of an 
SDS-PAGE gel and by Western blot. 
 
 
FLAG-TAGGING OXR2 
Induction of FLAG-tagged OXR2 
A strain of BL21 cells that had been transformed in the manner described above with a 
pcDNA3-OXR2-FLAG plasmid was obtained from Dr.  Volkert’s lab.  This strain was induced 
in the same manner described above.  The only exception in this case was that strain MV3594 
was not used as a control.   
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RESULTS 
 
HIS-TAGGING OXR2 
The initial purpose of this project was to design, construct, and express in E.  coli a 
plasmid containing a gene for human OXR2 fused with a His-tag.   
 
Creation of Plasmid Encoding His-Tagged OXR2 
A  PCR product was created using primers 329 and 330, and plasmid pMV1200 as 
template, which encodes the wild type version of human OXR2.  These primers were designed to 
produce DNA encoding the carboxyl-terminal end of the OXR2 protein with the addition of six 
histidine residues, a stop codon, and a HinDIII site (See Figure 9).  In order to produce a full 
length, His-tagged form of OXR2, pMV1200 (which contains full length OXR2) was digested 
with HinDIII and PstI, and the smaller fragment was replaced with the PCR product that had also 
been digested by HinDIII and PstI.  The product was a full length OXR2-his6 in a pTrc vector 
(See Figure 9). 
The predicted PCR product is 891 bp in length.  The PCR reaction was analyzed by gel 
electrophoresis (See Figure 10).  The results of this gel demonstrate that the PCR product 
obtained was approximately the correct size, and in great enough quantity to continue the cloning 
process (lane 2, Figure 10).  Sequencing of the PCR product was performed by Sequegen, using 
overlapping primers reading outward from the center of the PCR product and found to be correct 
(data not shown). 
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Figure 10: PCR Product Created Using Primers 329 and 330.  Gel electrophoresis of PCR 
product, actual length about 900 kbp (Lane 1: 1 kbp DNA ladder; 2: PCR product). 
 
 
The PCR product was inserted into pMV1200, as described above (See Figure 9), and 
then transformed into E.  coli.  Only two transformants containing plasmids pM1202 and 
pMV1203 were obtained and saved as strain numbers MV6658 and MV6659, respectively.  The 
plasmids carried by these strains were checked by digestion to see if they contained the correct 
PstI-HinDIII fragment.  To confirm that the PCR product had replaced the original carboxyl-
terminal end of OXR2 coding region in pMV1200, the plasmids were digested with PstI, 
HinDIII, or both enzymes.  The original parental plasmid with no insert contains one HinDIII 
site and two PstI sites (See Figure 11A).  The plasmid with the PCR product replacing the 
carboxyl-terminal OXR2 coding region contains one HinDIII site and one PstI site.  The second 
PstI site was removed during digestion of pMV1200 and was not present in the PCR product 
(See Figure 11).   
These two potential plasmids will be cut by PstI in different ways.  The original parental 
plasmid, pMV1200, will be cut twice by PstI, resulting in one large (6187 bp) and one small (812 
bp) fragment.  Double digestion will produce three fragments 6175, 812, and 12 bp in length. 
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The larger fragment produced by PstI digestion 6187 bp should be similar in size to the large 
fragment that results from double digestion (6175 kb).  
For the plasmid with an inserted PCR product, PstI digestion should yield only one 
fragment (expected size of 6999 bp), because the second PstI site has been removed.  The 
HinDIII digestions of these plasmids will yield a fragment of identical 6999 bp length, while a 
double digestion will produce two fragments (expected sizes 819 bp, 6180 bp). 
 
 
Figure 11:  Plasmid Maps.  (A) Plasmid map of pMV1200; (B) Predicted plasmid map of 
successful ligation products.   
 
Example screening data is shown for pMV1203 (see lanes 5-7, Figure 12).  The 
fragments of the plasmid cut with either HinDIII or PstI are slightly larger than the larger 
fragment in the double digestion.  The size of the single PstI fragment suggests that there is only 
one site located in this plasmid, so the PCR insert is present.   
The other plasmid, pMV1202, demonstrates similar results (See lanes 2-4, Figure 12), 
except that cutting with PstI (lane 3) resulted in several smaller fragments.  This banding was 
most likely due to a problem with the PstI digestion, since the total size of the fragments is larger 
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than the size of the full plasmid as determined by the HinDIII digestion.  Heterogeneity of 
plasmids is unlikely, since the HinDIII digest of the same plasmid preparation produced a single 
plasmid of the expected size.  Confirmation that the plasmid was correct was provided by 
sequencing of the plasmid by Sequegen, which shows that this plasmid is capable of producing 
full length OXR2-his6 (data not shown). 
 
Figure 12: Digestion Screening of Transformant Plasmids pMV1202 and pMV1203.  
Potentially positive plasmid DNAs pMV1202 and pMV1203 were extracted from transformants 
MV6658 and MV6659, respectively (Lane 1: 1 kbp DNA ladder; 2: pMV1202 cut with HinDIII; 
3: pMV1202 cut with PstI; 4: pMV1202 cut with HinDIII and PstI; 5: pMV1203 cut with HinDIII; 
6: pMV1203 cut with PstI; 7: pMV1203 cut with HinDIII and PstI; 8: pMV1200 cut with HinDIII; 
9: pMV1200 cut with PstI).  pMV1202 positives are seen in lanes 2-4, while pMV1203 positives 
are seen in lanes 5-7.  (The lack of a 812 bp band in lane 9 is circled for emphasis)  
 
The transformation efficiency of the competent Q cells using the ligation product 
described above was very low (data not shown).  Several transformation and electroporation 
trials yielded only two positive transformant strains, named MV6658 and MV6659.   
Transformation efficiencies were also low in the transformation and electroporation of 
pMV1200 (encoding WT human OXR2), which was used as a positive control of transformation.  
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It is possible that this poor transformation efficiency was due to a strong selection against the 
wild type plasmid in the cell.  To test this, pMV1200 and ligation product were transformed into 
competent Q cells and grown at 30°C overnight instead of 37°C.  These conditions improve 
results when transforming cells with plasmids that encode toxic proteins.  The transformation 
efficiency of this transformation was much greater than the other transformations (data not 
shown), supporting the hypothesis of a selection against the wild type plasmid.  In addition, a 
pTrc99A vector control plasmid was also used in this transformation. This plasmid does not 
express OXR2, and should not be as toxic to the cells. The transformation efficiency using this 
plasmid was much higher than the efficiency when using the ligation product.  This also supports 
the claim of selection against the OXR2-expressing plasmid.  Due to time constraints, these 
pTrc/OXR2-his6 plasmids were not used in subsequent induction experiments in this project, but 
were donated to Dr.  Volkert’s laboratory for use in future experiments. 
 
Induction of His-Tagged OXR2 
The cloned OXR2-his6 was expressed in E.  coli.  Because OXR2-his6 was cloned into a 
vector just downstream of a Trc promoter that is controlled by a lacI operator site, the gene was 
induced with IPTG.  When using strain MV6659, no protein bound the His-antibody used in the 
Western blotting (data not shown).  Sequencing by Sequegen determined that this was due to a 
point mutation in the His-tag (data not shown).  Thus no further experiments were performed 
with strain MV6659, and instead strain MV6658 was used in the induction and purification 
experiments. 
 The induction of MV6658 was analyzed by Coomassie stained SDS-PAGE and Western 
blot (See Figure 13).  Lanes 2 - 5 of the SDS-PAGE (Figure 13A) show cell extracts from IPTG-
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induced MV6658 at 0, 1, 2, and 3 hours, respectively.  A clear increase of a band at 
approximately the 106.9 kDa can be seen in these rows.  This is the expected size of OXR2-his6.  
This increase is seen to be weaker in rows 6 – 9 containing protein extract from uninduced 
MV6658 at 0, 1, 2, and 3 hours, and is absent in rows 10 – 13 containing protein extract from 
IPTG induced MV3594 (no OXR2).  Several other lower molecular weight bands also show an 
increase in the induced MV6658, but not in induced MV3594 (no OXR2), or in uninduced 
MV6658.  These bands are located at slightly greater than 75 kDa and slightly less than 75 kDa. 
 A Western blot was performed (Figure 13B) to determine whether the induced bands of 
interest from Figure 13A had an intact His-tag.  A band at about 106.9 kDa, presumably 
representing full-length OXR2-his6 is seen in the induced cells (Lanes 2-5, Figure 13B).  These 
bands are weaker in uninduced cells (Lanes 6-9, Figure 13B) and absent in the induced vector 
control (Lanes 10-13, Figure 13B).  There are also several smaller proteins that contain a His-tag 
in induced MV6658 and in uninduced MV6658 that are not found in the parent strain MV3594.  
These smaller proteins may be degradation products of OXR2-his6. 
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Figure 13: Analysis of His-Tagged OXR2 Induction in Strain MV6658.  (A) Coomassie stain 
of SDS-PAGE analysis of OXR2-his6 induction, full length OXR2-his6 circled in red.  (B) 
Western blot analysis of OXR2-his6 induction, full length OXR2-his6 circled in white.  (Lane 1: 
Precision Plus Protein Standards; 2: Induced strain MV6658 at 0 hours; 3: Induced strain MV6658 
at 1 hour; 4: Induced strain MV6658 at 2 hours; 5: Induced strain MV6658 at 3 hours; 6: 
Uninduced strain 6658 at 0 hours; 7: Uninduced strain 6658 at 1 hour; 8: Uninduced strain 6658 at 
2 hours; 9: Uninduced strain 6658 at 3 hours; 10: Induced strain MV3594 at 0 hours; 11: Induced 
strain MV3594 at 1 hour; 12: Induced strain MV3594 at 2 hours; 13: Induced strain MV3594 at 3 
hours). 
 
Purification of His-Tagged OXR2 
 In order to purify OXR2-his6, uninduced or induced cells were lysed by freeze-thawing 
and by treatment with lysozyme, and the protein extract was run on a His-spin protein miniprep 
column to purify the His-tagged protein.  Figure 14A shows an SDS-PAGE analysis of the 
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purification of OXR2-his6 from transformant strain MV6658.  Lanes 6 and 7 of Figure 14A 
show the pellet and cell extract, respectively, from the induced transformant strain MV6658, 
showing a very strong band at the expected 106.9 kDa size of full length OXR2-his6.  This band 
is absent in the induced vector control strain encoding no OXR2 (MV3594, lanes 2 and 3, Figure 
14A) and much weaker in the uninduced MV6658 (lanes 4 and 5, Figure 14A).  While most of 
the full length OXR2-his6 appears in the pellet of the induced transformant strain (lane 6, Figure 
14A), enough appears in the supernatant to purify on the His-column.  This band and other 
smaller bands are also found in the final purified sample (lane 11, Figure 14A).  These smaller 
bands may be degradation products seen in the OXR2-his6 induction experiments. 
Western blot analysis of the column-purified His-protein demonstrates that the 106.9 kDa 
band identified as OXR2-his6 contains an intact His-tag (See Figure 14B).  The smaller 
fragments also contain intact His-tags (See Figure 14B).  Because the oxygen resistance-
inducing domain of OXR2 is located in the carboxyl-terminal end of the protein, and the amino 
terminal end of the protein is not necessary to confer this resistance, the smaller products in this 
purification should still be useful in functional studies (Durand, et al., 2007). 
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Figure 14: Analysis of His-Tagged OXR2 Purification in Strain MV6658.  (A) Coomassie 
stain of SDS-PAGE analysis of OXR2-his6 purification, full length OXR2-his6 circled in red.  (B) 
Western blot analysis of OXR2-his6 purification, full length OXR2-his6 circled in white.  (Lane 1: 
Precision Plus Protein Standards; 2: Induced MV3594 pellet; 3: Induced MV3594 supernatant; 4: 
Uninduced MV6658 pellet; 5: Uninduced MV6658 supernatant; 6: Induced MV6658 pellet; 7: 
Induced MV6658 supernatant; 8: His-spin protein miniprep flow-through; 9: His-spin protein 
miniprep wash 1; 10: His-spin protein miniprep wash 2; 11: His-spin protein miniprep purified 
protein). 
 
FLAG-TAGGING OXR2 
A secondary goal of this project was to also express FLAG-tagged OXR2.  This tagged 
protein would be especially useful for metal-binding studies, since the His portion of OXR2-his6 
would directly bind metals.  An inducible E.  coli strain (MV6660) for producing this protein 
was previously constructed. 
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Induction of FLAG-Tagged OXR2 
 The results of the induction of the OXR2-FLAG (Figure 15) were similar to those of the 
OXR2-his6 induction.  A band at the 106.9 kDa expected length of full length OXR2 is found in 
the SDS-PAGE analysis of induced strain MV6660 (Lanes 2-5, Figure 15A) that is weaker in the 
uninduced MV6660 (Lanes 6 and 7, Figure 15A).  Unlike in the OXR2-his6 induction, no 
smaller bands are noticeable that are darker in the induced relative to the uninduced.  Thus, full 
length OXR2-FLAG appears to be induced.   
 The Western blot analysis (Figure 15B) also supports this finding.  A clear band of 
FLAG-tagged protein is found in greater quantity in the induced strain than in the uninduced 
strain.  The marker bands in the first lane of this gel were very light, and after transfer, were also 
difficult to read, so this may explain the slight discrepancy between the sizes in the Western blot 
versus the SDS-PAGE gel.  Two, very faint, smaller bands are also present on the Western blot 
(circled for emphasis in Figure 15B).  These bands were easily observed in the original film from 
this Western blot, but are difficult to see in the reproduction of the film in this paper.  These 
bands may be degradation product of OXR2-FLAG.  They are not readily visible in the SDS-
PAGE analysis, as the OXR2-his6 fragments were, so they are present in far less quantity.  Thus, 
OXR2-FLAG may be more stable in the cell than OXR2-his6. 
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Figure 15: SDS-PAGE Analysis of FLAG-Tagged OXR2 Purification in Strain MV6660.  (A) 
Coomassie stain of SDS-PAGE analysis of OXR2-FLAG induction, full length OXR2-FLAG 
circled in red.  (B) Western blot analysis of OXR2-FLAG induction, full length OXR2-FLAG 
circled in white, potential OXR2-FLAG degradation products are circled in red.  (Lane 1: 
Precision Plus Protein Standards; 2: Induced MV6660 at 0 hours; 3: Induced 6660 at 1 hour; 4: 
Induced 6660 at 2 hours; 5: Induced 6660 at 3 hours; 6: Uninduced 6660 at 0 hours; Uninduced 
6660 at 3 hours). 
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DISCUSSION 
HIS-TAGGING OXR2 
 The main goal of this project was to tag human OXR2 to assist its purification to allow 
subsequent functional studies.  This goal was accomplished, as a His-tagging and purification 
system was used to purify OXR2.  The data showed a band of the 106.9 kDa expected size of full 
length human OXR2 strongly induced by IPTG by 3 hrs post-induction.  The band was clearly 
visible on Coomassie stained SDS-PAGE and His-immunoblot analyses of cell lysates, in the 
pellet fraction of induced cells, and in the final purified supernatant.  However, full length OXR2 
was not the only, or even the major product purified.  The two major products of the purification 
were slightly larger than 75 kDa and slightly smaller than 75 kDa.  These proteins were found in 
the induced transformant strain, but not in the vector control strain (See Figures 13 and 14), 
which suggests that these are fragments of OXR2-his6.  And since they are recognized by the 
anti-His antibody, they contain the His-tag, and must represent fragments of the in-frame 
carboxyl-terminal end of the protein. 
 Previous studies have determined that a fragment of OXR2 extending from amino acids 
657 – 942 (a 34.06 kDa fragment of the protein) is sufficient to protect a cell from oxidative 
damage (Durand, et al., 2007).  The fragments in the His purification in this project, are larger 
than this minimum functional requirement, which suggests the major products of the His 
purification process should be functional. 
 Sequencing of the OXR2-his6 containing plasmid pMV1202 demonstrated that the 
plasmid is capable of producing a full length OXR2-his6 (data not shown).  The mixture of full 
length and truncated His-tagged OXR2 fragments in the final purification and induction could be 
explained in several ways.  One likely explanation is that the full length protein is being partially 
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degraded in E.  coli or by proteases after cell lysis during cell extract preparation.  This would 
explain why the His-tag is still in frame in these protein fragments.  Another possible explanation 
for the fragmented product is that when the transformant strain MV6658 is grown and induced, 
there is a strong selection against the plasmid encoding full length protein.  The selection would 
not support maintenance of the plasmid in the cell, and mutations would accumulate, leading to a 
mixture of mutated plasmids in the strain and a mixture of protein products in the cell that 
initiate translation at methionine codons that are in frame with the His-tag.  A topic for future 
research should include determining which of these two scenarios, if either, is responsible for the 
smaller protein fragments during induction.  But overall, the His-Tag purification yielded several 
OXR2 species that can be used in future studies. 
 
FLAG-TAGGING OXR2 
 The second goal of this project was to produce a FLAG-tagged OXR2 as an alternative 
source of OXR2 for metal binding assays, since the His portion of OXR2-his6 would directly 
bind metals.  This OXR2-FLAG strain of E.  coli was obtained from Myles Brown and 
coworkers (Durand, et al., 2007), and in this project produced a full length product with minimal 
degradation.   
 
TOPICS FOR FUTURE STUDIES 
There is much to learn about OXR2.  The tagged OXR2 purified in this project can now 
be used to perform biochemical and functional studies.  For example, an OXR2-FLAG molecule 
could be used to study OXR2’s metal binding properties.  The growth of yeast strains containing 
OXR1, which is homologous to human OXR2, is enhanced by the addition of metal ions (Anita 
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Fenton, personal communication).  An OXR2-his6 could be used to find other types of cofactors, 
such as flavin, that are required for OXR2 function.  Both tagged proteins can be used in other 
structural and functional studies of OXR2.  A greater knowledge of the mechanism of oxidative 
protection of OXR2 could lead to greater insight into prevention of human disorders caused by 
oxidative cell damage.   
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